CHEK2 and breast cancer: One patient with bilateral BC and one other heterozygous BC patient also carried a pathogenic CHEK2 c.1100del variant; no other high- or moderate-risk BC predisposition variants had been found in the NTHL1 c.244C>T carriers from Helsinki.